Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-04-18
2006-04-18
Wang, Andrew (Department: 1635)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C424S009100, C424S009340, C424S130100, C424S134100, C424S155100, C435S007230, C530S350000, C530S388100, C530S389100
Reexamination Certificate
active
07029859
ABSTRACT:
The present invention relates to methods for the diagnosis, evaluation and treatment of metastatic diseases using metastatic sequences, such as caveolin, to target metastatic cells. According to the methods of the present invention, certain cancers, including metastatic prostate cancer, may be treated by therapies which suppress expression of the caveolin gene. The present invention relates to biological technologies designed to block the activity of caveolin or the function of caveolae, including vector delivery of antisense caveolin sequences, the use of anti-caveolin antibodies, the use of promoters, and other approaches targeting the expression of caveolin.
REFERENCES:
patent: 4317818 (1982-03-01), Benson et al.
patent: 4925835 (1990-05-01), Heston
patent: 5116615 (1992-05-01), Gokcen et al.
patent: 5260224 (1993-11-01), Stossel et al.
patent: 5633161 (1997-05-01), Shyjan
patent: 5783182 (1998-07-01), Thompson
patent: 5834234 (1998-11-01), Gallo
patent: WO86/03226 (1986-06-01), None
patent: WO94/04196 (1994-03-01), None
patent: WO94/16737 (1994-08-01), None
patent: WO94/28129 (1994-12-01), None
patent: WO95/19369 (1995-07-01), None
patent: WO96/30389 (1996-10-01), None
patent: WO97/09055 (1997-03-01), None
patent: WO97/18454 (1997-05-01), None
patent: WO99/22773 (1999-05-01), None
Robert G. Parton, Ultrastructural Localization of Gangliosides; GM 1 is concentrated in Caveolae. The Journal of Histochemistry and Cytochemistry, vol. 42, No. 2, pp. 155-166.
M. Wu et al., Clustering of GPI-Anchored Folate Receptor Independent of Both Cross-Linking and Association with Caveolin. The Journal of Membrane Biology, 159, pp. 137-147.
William S. Garver et al., Increased Expression of Caveolin—1 in Heterozygous Niemann—Pick Type II Human Fibroblasts. Biochemical and Biophysical Research Communications 236, pp. 189-193.
Robert G. Parton, Caveolin—3 Associates with Developing T-tubules during Muscle Differentiation, The Hournal of Cell Biology, vol. 136, No. 1, Jan. 13, 1997, pp. 137-154.
Olivier Feron et al., Endothelial Nitric Oxide Synthase Targeting to Caveolae, The Journal of Biological Chemistry, vol. 271, No. 37, pp. 22810-22814.
Robert H. Moore et al., Ligand—stimulated B2-adrenergic receptor internalization via the constitutive endocytic pathway into rab5-containing endosomes, Journal of Cell Science 108, pp. 2983-2991.
Philipp E. Scherer et al., Caveolin Isoforms Differ in Their N-terminal Protein Sequence and Subcellular Distribution The Journal of Biological Chemistry, vol. 270, No. 27, pp. 16395-16401.
Dennis Brown et al., Antigen retrieval in cryostat tissue sections and cultured cells by treatment with sodium dodecyl sulfate (SDS), Histochem Cell Biol (1996) 105: pp. 261-267.
Kenneth S. Song et al., Expression of Caveolin—3 in Skeletal, Cardiac, and Smooth Muscle Cells, The Journal of Biological Chemistry, vol. 271, No. 25, pp. 15160-15165.
Guang Yang et al., Association of Caveolin Protein with Prostate Cancer Progression, No. 1742.
Keyes, S.R. et al., Antiangiogenic agents (TNP-470 and minocycline): Effects on caveolin—1 expression and survival in prostate and breast cancer cells, No. 1383.
Mouraviev et al. The Journal of Urology, vol. 168, pp. 1589-1596, Oct. 2002.
Hill, Richard, “Metastasis”, Chapter 11 from The Basic Science of Oncology, Tannock et al., Eds., McGraw-Hill, NY, 1992, pp. 178-195.
Parton, RG Ultrastructural Localizationof Gangliosides; GM1 is concentrated in caveolae. Journal of Histochemistry and Cytochemistry, 1994 vol. 42:155-166.
Glenney et al. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated n tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci, 1992 vol. 89(21):10517-21.
Yang et al, Elevated Expression of Caveolin is Associated with Prostate and Breast Cancer, Clinical Cancer Research, 1998 vol. 4:1873-1880.
International Search Report for PCT/US98/23542 mailed Aug. 27, 1999.
Shimura, et al. Abstract: American Urological Association 94th Annual Meeting, Dallas, TX “Reduction in Lysyl Oxidase Expression is an Independent Preditor of Recurrence Following Radical Prostatectomy” May 1-6, 1999.
Goltsov, et al. “A novel p-53-regulated gene encoding a four transmembrane domain protein in mouse prostate cancer cells”, AACR Annual Meeting, Apr. 10-14, 1999, Philadelphia, PA.
Thompson, “Metastasis-related Genes in Prostate Cancer: The Role of Caveolin-1”,Cancer and Metastasis Reviews, vol. 17, pp. 439-442, 1999.
Nasu, et al. “Supression of caveoline expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells”Nature Medicine, vol. 4, No. 9, pp. 1062-1064, Sep., 1998.
Nelson, Joel B. “Alternatives to death: Understanding androgen-independent prostate cancer”,Nature Medicine, vol. 4, No. 9, pp. 1011-1012, Sep. 1998.
Yang et al. “Elevated Expression of Caveolin Is Associated with Prostate and Breast Cancer”,Clinical Cancer Research, vol. 4, pp. 1873-1880, Aug., 1998.
Anderson, Nature 392/Supp. 25-30, Apr. 1998.
Ren, et al. “Identification and characterization of p53 regulared genes in a mouse prostate cancer cell line”, AACR Annual Meeting, Mar. 28-Apr. 1, 1998, New Orleans, LA.
Ren, et al. “Reduced Lysyl Oxidase in RNA Levels in Experimental and Human Prostate Cancer”,Cancer Research, vol. 58, p. 1-6, Mar. 15, 1998.
Bist et al. “Two sterol regulatory element-like sequences mediate up-regulatin of caveolin gene transcription in response to low density lipoprotein free cholesterol”,Proc. Natl. Acad. Sci. USA, vol. 94, pp. 10693-10698, Sep. 1997
Stapleton, et al. “Primary Human Prostate Cancer Cells Harboring p53 Mutations are Clonally Expanded in Metastates”,Clinical Cancer Research, vol. 3, pp. 1389-1397 (Aug. 1997).
Yang, et al. “Association of Caveolin Protein with Prostate Cancer Progression”, Journal of Urology, vol. 157, No. 4, p. 446, Abstract #1742 (Apr. 1997).
Fielding, et al. “Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblasts monolayers”,Proc. Natl. Acad. Sci. USA, vol. 94, pp. 3753-3758, Apr. 1997.
Shanley, et al. “Transforming growth factor-β, increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells”, Journal of Vascular Surgery, vol. 15, No. 3, pp. 446-452 (Mar. 1997).
Peyrol, et al. “Lysyl Oxidase Gene Expression in the Stromal Reaction to in Situ and Invasive Ductal Breast Carcinoma”,American Journal of Pathology, vol. 150, No. 2, pp. 497-507 (Feb. 1997).
Jourdan-Le Saux, et al. “Functional Analysis of the Lysyl Oxidase Promotor in Myofibroblast-Like Clones of 3T6 Fibroblast”, Journal of Cellular Biochemistry 64: 328-341, Feb. 1997.
Guarini et al., “Transfer of the Interleukin-2 Gene into Human Cancer Cells Induces Specific Antitumor Recognition and Restores the Expression of CD3/T-Cell Receptor Associated Signal Transduction Molecules,”Blood, vol. 89, No. 1, pp. 212-218 (Jan. 1, 1997).
Yang et al. “Perineural Invasion of Prostate Carcinoma Cells is Associated with Reduced Apoptotic Index”,Cancer, vol. 78, No. 6, pp. 1267-1271 (Sep. 15, 1996).
Sehgal, et al., “Transforming Growth Factor β1 Stimulates Contrasting Responses in MetastaticversusPrimary Mouse Prostate Cancer-derived Cell Lines in Vito”,Cancer Research, vol. 56, pp. 3359-3365 (Jul. 15, 1996).
Easthan et al. “Prostate Cancer Gene Therapy:Herpes simplexVirus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer Models”,Human Gene Therapy, vol. 7, pp. 515-523, Mar. 1, 1996.
Thompson et al. “Exogenous Leukocyte and Endogenous Elastases Can Mediate Mitogenic Activity in Pulmonary Artery Smooth Muscle Cells by Release of Extracellular Matrix-Bound Basic Fibroblast Growth Factor”,Journal of Cellular Physiology
Baylor College of Medicine
Gibbs Terra C.
Vinson & Elkins LLP
Wang Andrew
LandOfFree
Sequences for targeting metastatic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sequences for targeting metastatic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequences for targeting metastatic cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3586532